بدائل البحث:
clinical decrease » clinical disease (توسيع البحث), clinical case (توسيع البحث), linear decrease (توسيع البحث)
greatest decrease » treatment decreased (توسيع البحث), greater increase (توسيع البحث)
side decrease » sizes decrease (توسيع البحث), fid decreased (توسيع البحث), step decrease (توسيع البحث)
clinical decrease » clinical disease (توسيع البحث), clinical case (توسيع البحث), linear decrease (توسيع البحث)
greatest decrease » treatment decreased (توسيع البحث), greater increase (توسيع البحث)
side decrease » sizes decrease (توسيع البحث), fid decreased (توسيع البحث), step decrease (توسيع البحث)
-
1
Inotodiol decreases clone formation in HCC cells.
منشور في 2025"…Chemicals and chemotherapeutic agents have been experiencing problems such as side effects and drug resistance in the treatment of HCC, which cannot meet the needs of clinical treatment. …"
-
2
-
3
-
4
-
5
Centrifuged FMT products consistently exhibit the lowest median log<sub>10</sub> drop of CFU/g following freezing and lyophilization. In contrast, unprocessed feces exhibited the greatest median log<sub>10</sub> drop and had a statistically significant loss of bacterial viability across both storage conditions....
منشور في 2025"…In contrast, unprocessed feces exhibited the greatest median log<sub>10</sub> drop and had a statistically significant loss of bacterial viability across both storage conditions. …"
-
6
Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque count.
منشور في 2025"…Additionally, the plots on the right side display the average plaque count across the cohorts. …"
-
7
-
8
-
9
-
10
-
11
-
12
Trypan blue dye exclusion assay for cell viability evaluation (% of control).
منشور في 2025الموضوعات: -
13
-
14
Rate of apoptosis in MDA-MB-231 cells (ATO: 2.5 μM and GCB: 22.5 μM, 48 h, at 37°C).
منشور في 2025الموضوعات: -
15
-
16
-
17
-
18
Rate of apoptosis in MCF-7 cells (ATO: 2.5 μM and GCB: 22.5 μM, 48 h, at 37°C).
منشور في 2025الموضوعات: -
19
-
20